VentriPoint Diagnostics (CVE:VPT) Trading Down 14.7% – Here’s What Happened
by Kim Johansen · The Markets DailyVentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shares fell 14.7% during mid-day trading on Wednesday . The stock traded as low as C$0.15 and last traded at C$0.15. 266,015 shares were traded during trading, a decline of 10% from the average session volume of 294,436 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Trading Down 9.1 %
The firm has a fifty day moving average price of C$0.11 and a 200-day moving average price of C$0.13. The company has a market capitalization of C$24.33 million, a price-to-earnings ratio of -4.63 and a beta of 0.39. The company has a debt-to-equity ratio of -58.56, a quick ratio of 6.67 and a current ratio of 0.28.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Further Reading
- Five stocks we like better than VentriPoint Diagnostics
- 3 Best Fintech Stocks for a Portfolio Boost
- 3 Undervalued Stocks You Can Buy at a Discount Now
- What is Forex and How Does it Work?
- AMD Stock: Can the PC Refresh Cycle Spark a Rally?
- Business Services Stocks Investing
- Micron Stock Spikes 7%—3 Key Catalysts Behind the Move